Zydus Cadila gets DCGI nod for world's first drug to treat liver disease

The Ahmedabad-based company said the approved product is the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic SteatoHepatitis (NASH) which is a progressive disease of the liver. The condition starts with fat accumulation in the liver known as non-alcoholic fatty liver disease and progress to cirrhosis and liver failure.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2vIH5DH
via IFTTT